Indivior Pharmaceuticals, Inc.
Indivior Pharmaceuticals, Inc. (INDV) — Form 425: SEC filing
About this filing
Indivior Pharmaceuticals, Inc. (INDV) filed Form 425 (sec filing) with the SEC on Oct 6, 2026.
Key facts
- Document
- 425
More INDV filings
- 8-K
Filed Nov 2, 2026
- 10-Q
Filed Oct 29, 2026
- 425
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
- 8-K
Filed Oct 15, 2026
- 8-K
Filed Oct 6, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.